SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-130816
Filing Date
2005-06-24
Accepted
2005-06-24 15:00:34
Documents
5
Period of Report
2005-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26052
2 REGISTRATION RIGHTS AGREEMENT dex41.htm EX-4.1 75309
3 INDENTURE dex991.htm EX-99.1 618255
4 PRESS RELEASE dex992.htm EX-99.2 3531
5 GRAPHIC g85088img004.jpg GRAPHIC 5939
  Complete submission text file 0001193125-05-130816.txt   733143
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25317 | Film No.: 05914930
SIC: 2836 Biological Products, (No Diagnostic Substances)